Shikonin, an inhibitor of inflammasomes, inhibits Epstein-Barr virus reactivation
- 6 August 2023
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 217, 105699
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Compounds fromArnebia euchromaand Their Related Anti-HCV and Antibacterial ActivitiesPlanta Medica, 2011
- Anti-adenovirus Activities of Shikonin, a Component of Chinese Herbal Medicine in VitroBiological and Pharmaceutical Bulletin, 2011
- Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycleJournal of Clinical Virology, 2006
- Shikonin, a Component of Chinese Herbal Medicine, Inhibits Chemokine Receptor Function and Suppresses Human Immunodeficiency Virus Type 1Antimicrobial Agents and Chemotherapy, 2003
- Cellular pharmacology studies of shikonin derivativesPhytotherapy Research, 2002
- Endogenous TGF‐β contributes to the induction of the EBV lytic cycle in two burkitt lymphoma cell linesInternational Journal of Cancer, 1994
- Calcium Modulation Activates Epstein-Barr Virus Genome in Latently Infected CellsScience, 1986
- Cross‐linking of cell surface immunoglobulins induces epstein‐barr virus in burkitt lymphoma linesInternational Journal of Cancer, 1984
- Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrateVirology, 1979
- Persisting oncogenic herpesvirus induced by the tumour promoter TPANature, 1978